Asgard Therapeutics AB
559184-0136ActivePioneering in vivo cell reprogramming for next-generation cancer immunotherapy.
Yleiskatsaus
- 10–19
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2018
- Perustettu
Avainpäättäjät
Alexey Zeifman
Board Member
Philipp Müller
Board Member
Nadiya Ishnazarova
Board Member
Ignacio Melero
Clinical Advisory Board Member
+18 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Asgard Therapeutics is a Swedish private biotech company focused on revolutionizing cancer immunotherapy. Their core mission involves pioneering direct cell reprogramming technologies. Specifically, they aim to develop scalable methods for the in vivo conversion of cancer cells into functional antig...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Bioteknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE559184013601
Päättäjät
22 yhteystietoa FunnelfeedrissäAlexey Zeifman
Board Member
Philipp Müller
Board Member
Nadiya Ishnazarova
Board Member
Ignacio Melero
Clinical Advisory Board Member
Johanna Olweus
Scientific Advisory Board Member
Shane Olwill
Chief Development Officer
João Ribas
Board Member
Jan Villadsen
Head of Finance
Ulrich Lauer
Clinical Advisory Board Member
Cristiana Pires
Co-founder and CEO
Fábio Rosa
Co-founder and VP of Research
Jonas Jendi
Board Member
Martin Bonde
Chair of the Board
Joshua Brody
Scientific Advisory Board Member
Fiona MacLaughlin
Board Member (Johnson & Johnson Innovation – JJDC, Inc.)
Brian Brown
Scientific Advisory Board Member
Aleksei Zeifman
Board Member (RV Invest)
Filipe Pereira
Co-founder and Head of Innovation
Frank Hennecke
Head of CMC
Wolfram Brugger
Chief Medical Officer
Aurélien Marabelle
Clinical Advisory Board Member
Cristina Csimma
Independent Board Member
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäSACRA Therapeutics AB
0 työntekijätSACRA pioneers novel RNA-targeting therapies for incurable cancers.
Anocca AB
100–199 työntekijätEngineering precision T-cell immunotherapies for hard-to-treat cancers.
Lokon Pharma AB
10–19 työntekijätDeveloping novel gene engineering vectors for cancer immunotherapy.
Valo Therapeutics Oy
Developing novel peptide-coated oncolytic virus immunotherapies for cancer.
Theralia AB
0 työntekijätPioneering biotech revolutionizing drug delivery via TOUCAN technology.
Selaa lisää
Kysymyksiä yrityksestä Asgard Therapeutics AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo